Prophylactic administration of abatacept (CTLA4-Ig; BMS-188667) prevents disease induction and bone destruction in a rat model of collagen-induced arthritis

por Kliwinski, C, Kukral, D, Postelnek, J, Krishnan, B, Killar, L, Nadler, S, Townsend, R
Publicado 2005